KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Zimmer Biomet Holdings (ZBH) EBIT Margin (2016 - 2025)

Zimmer Biomet Holdings has reported EBIT Margin over the past 17 years, most recently at 6.89% for Q4 2025.

  • Quarterly results put EBIT Margin at 6.89% for Q4 2025, down 1234.0% from a year ago — trailing twelve months through Dec 2025 was 13.34% (down 340.0% YoY), and the annual figure for FY2025 was 13.34%, down 340.0%.
  • EBIT Margin for Q4 2025 was 6.89% at Zimmer Biomet Holdings, down from 17.55% in the prior quarter.
  • Over the last five years, EBIT Margin for ZBH hit a ceiling of 19.23% in Q4 2024 and a floor of 1.55% in Q4 2022.
  • Median EBIT Margin over the past 5 years was 14.95% (2022), compared with a mean of 13.27%.
  • Biggest five-year swings in EBIT Margin: soared 2675bps in 2021 and later tumbled -1234bps in 2025.
  • Zimmer Biomet Holdings' EBIT Margin stood at 7.53% in 2021, then tumbled by -121bps to 1.55% in 2022, then soared by 1277bps to 18.26% in 2023, then rose by 5bps to 19.23% in 2024, then plummeted by -64bps to 6.89% in 2025.
  • The last three reported values for EBIT Margin were 6.89% (Q4 2025), 17.55% (Q3 2025), and 14.44% (Q2 2025) per Business Quant data.